Curasen Therapeutics Patents – Insights & Stats (Updated 2023)

Curasen Therapeutics has a total of 105 patents globally, out of which 5 have been granted. Of these 105 patents, more than 87% patents are active. The United States of America is where Curasen Therapeutics has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Curasen Therapeutics.

Curasen Therapeutics was founded in 2016. Curasen Therapeutics is a biotechnology firm dedicated to finding and developing treatments for neurodegenerative illnesses, such as Parkinson’s disease, Alzheimer’s disease, and other neurodegenerative disorders.

Do read about some of the most popular patents of Curasen Therapeutics which have been covered by us in this article and also you can find Curasen Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Curasen Therapeutics patent portfolio.

How many patents does Curasen Therapeutics have?

Curasen Therapeutics has a total of 105 patents globally. These patents belong to 12 unique patent families. Out of 105 patents, 92 patents are active.

How Many Patents did Curasen Therapeutics File Every Year?

Curasen Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCurasen Therapeutics Applications FiledCurasen Therapeutics Patents Granted
202393
20226
2021382
202040
201912

How many Curasen Therapeutics patents are Alive/Dead?

Worldwide Patents

Curasen Therapeutics Patent Portfolio

How Many Patents did Curasen Therapeutics File in Different Countries?

Curasen Therapeutics Worldwide Patent Filing

Countries in which Curasen Therapeutics Filed Patents

CountryPatent
United States of America16
Europe10
Canada10
Japan9
Australia9
Hong Kong (S.A.R.)8
Mexico6
China6
Korea (South)5
Russian Federation2
New Zealand2
Argentina2
Taiwan2
Israel2
India2
South Africa1
Brazil1

Where are Research Centers of Curasen Therapeutics Patents Located?

The Research Center for Curasen Therapeutics is the United States of America.

What Percentage of Curasen Therapeutics US Patent Applications Were Granted?

Curasen Therapeutics (Excluding its subsidiaries) has filed 10 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100%.

Below are the key stats of Curasen Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Curasen Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Dla Piper Llp10100%

What are Curasen Therapeutics key innovation segments?

What Technologies are Covered by Curasen Therapeutics?

The chart below distributes patents filed by Curasen Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Curasen Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Curasen Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Curasen Therapeutics?

Related Articles

Xiamen Easo Patents – Insights & Stats (Updated 2024)

Xiamen Easo has a total of 681 patents globally, out of which 536 have been granted. Of these 681 patents, more than 59% patents are active. China is where Xiamen Easo has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.